13F-HR 1 form13fhr.txt NONE UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 13F Form 13F COVER PAGE Report for the Calendar Year or Quarter Ended: 9/30/2012 Check here if Amendment []; Amendment Number: ------- This Amendment (Check only one.): [] is a restatement. [] adds new holdings entries. Institutional Investment Manager Filing this Report: Name: Ayer Capital Management, LP Address: 230 California Street, Suite 600 San Francisco, CA 94111 Form 13F File Number: The institutional investment manager filing this report and the person by whom it is signed hereby represent that the person signing the report is authorized to submit it, that all information contained herein is true, correct and complete, and that it is understood that all required items, statements, schedules, lists, and tables, are considered integral parts of this submission. Persons Signing this Report on Behalf of Reporting Manager: Name: Jay Venkatesan Title: Managing Member Phone: 415-874-4800 Signature, Place, and Date of Signing: /s/ Jay Venkatesan San Francisco, CA 11/14/2012 --------------------------------- --------------------------------- ---------- [Signature] [City, State] [Date] Report Type (Check only one): [X] 13F HOLDINGS REPORT. (Check here if all holdings of this reporting manager are reported in this report.) [ ] 13F NOTICE. (Check here if no holdings reported are in this report, and all holdings are reported by other reporting manager(s).) [ ] 13F COMBINATION REPORT. (Check here if a portion of the holdings for this reporting manager are reported in this report and a portion are reported by other reporting manager(s).) List of Other Managers Reporting for this Manager: Form 13F SUMMARY PAGE Report Summary: Number of Other Included Managers: 2 Form 13F Information Table Entry Total: 31 Form 13F Information Table Value Total: $ 236,961 -------------- (In Thousands) List of Other Included Managers: Provide a numbered list of the name(s) and 13F file number(s) of all institutional investment managers with respect to which this report is filed, other than the manager filing this report. No. Form 13F File Number Name 1 ACM Capital Partners, LLC ---- -------------------- ---------------------------------------------------- 2 Jay Venkatesan ---- -------------------- ----------------------------------------------------

FORM 13F INFORMATION TABLE COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8 ---------------------------- ---------------- --------- -------- ------------------- ---------- -------- ---------------------- VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGERS SOLE SHARED NONE ---------------------------- ---------------- --------- -------- ---------- --- ---- ---------- -------- ---------- ------ ---- ~~ALERE INC COM 01449J105 13,688 704,140 SH DEFINED 1,2 704,140 0 0~~ ARIAD PHARMACEUTICALS INC COM 04033A100 1015,~~481~~092 ~~608~~622,992 SH DEFINED 1,2 ~~608~~622,992 0 0 ARTHROCARE CORP COM 043136100 1317,~~459~~750 ~~459~~547,~~655~~835 SH DEFINED 1,2 ~~459~~547,~~655~~835 0 0 BIOLINERX LTD~~-SPONS~~ ~~ADR~~ SPONSORED ADR 09071M106 2,~~578~~516 1956,~~056,~~598 SH DEFINED 1,2 1956,~~056,~~598 0 0 BIOSPECIFICS TECHNOLOGIES CO COM 090931106 2,~~675~~766 142,424 SH DEFINED 1,2 142,424 0 0 CARDINAL HEALTH INC COM 14149Y108 86,~~945~~780 ~~212~~173,~~978~~989 SH DEFINED 1,2 ~~212~~173,~~978~~989 0 0 CHEMOCENTRYX INC COM 16383L106 5,~~003~~056 ~~333~~434,~~505~~769 SH DEFINED 1,2 ~~333~~434,~~505~~769 0 0 CELGENE CORP COM 151020104 915,~~278~~570 ~~144~~203,~~600~~800 SH DEFINED 1,2 ~~144~~203,~~600~~800 0 0 CELGENE CORP RIGHT 12/31/2030 151020112 12,~~131~~465 ~~601~~870,~~792~~993 SH DEFINED 1,2 ~~601~~870,~~792~~993 0 0 CIGNA CORP COM 125509109 8,~~272~~359 ~~188~~177,~~000~~200 SH DEFINED 1,2 ~~188~~177,~~000~~200 0 0 CYCLACEL PHARMACEUTICALS INC COM 23254L108 ~~568~~822 220,593 SH DEFINED 1,~~544~~2 220,~~163~~593 0 0 CYTOKINETICS INC COM 23282W100 417 500,000 SH DEFINED 1,2 1500,~~544,163~~000 0 0 DENDREON CORP NOTE 4.750% 6/1 24823QAB3 65,~~997~~919 6,190,000 PRN DEFINED 1,2 6,190,000 0 0 DYNAVAX TECHNOLOGIES CORP COM 268158102 1110,~~261~~655 2,~~606~~238,~~643~~543 SH DEFINED 1,2 2,~~606~~238,~~643~~543 0 0 ~~GRIFOLS~~ENDOLOGIX SINC ACOM ~~SPONSORED~~29266S106 ~~ADR 398438309 15~~13,~~245~~833 1,~~587~~000,~~971~~944 SH DEFINED 1,2 1,~~587~~000,~~971~~944 0 0 ~~HOLOGIC~~GRIFOLS ~~INC~~S ~~COM~~A ~~436440101~~SPONSORED 4ADR 398438309 18,~~173~~127 ~~231~~793,~~300~~985 SH DEFINED 1,2 ~~231~~793,~~300~~985 0 0 ~~IDENIX~~HOLOGIC ~~PHARMACEUTICALS~~ INC COM ~~45166R204~~436440101 125,~~486~~120 1252,~~212,218~~960 SH DEFINED 1,2 1252,~~212,218~~960 0 0 ~~INTERMUNE~~INSMED INC ~~NOTE~~COM 5PAR $.~~000%~~01 ~~3/0~~457669307 ~~45884XAD5 12~~14,~~107~~178 113,~~180~~116,~~000~~100 ~~PRN~~SH DEFINED 1,2 113,~~180~~116,~~000~~100 0 0 ~~LIGAND~~MCKESSON ~~PHARMACEUTICALS-CL~~CORP B COM ~~NEW~~58155Q103 ~~53220K504 2~~8,~~558~~435 ~~151~~98,~~028~~052 SH DEFINED 1,2 ~~151~~98,~~028~~052 0 0 ~~MCKESSON~~NEPTUNE ~~CORP~~TECH & BIORESSOURCES COM ~~58155Q103~~64077P108 82,~~846~~568 94650,~~352~~000 SH DEFINED 1,2 94650,~~352~~000 0 0 NPS PHARMACEUTICALS INC COM 62936P103 813,~~226~~432 ~~955~~1,~~409~~452,109 SH DEFINED 1,2 ~~955~~1,~~409~~452,109 0 0 OMEROS CORP COM 682143102 2,~~250~~115 225,000 SH DEFINED 1,2 225,000 0 0 ONCOTHYREON INC COM 682324108 1011,~~618~~302 2,~~268~~198,855 SH DEFINED 1,2 2,~~268~~198,855 0 0 ~~PALATIN~~PEREGRINE ~~TECHNOLOGIES~~PHARMACEUTICALS ~~INC~~IN COM ~~PAR~~NEW $713661904 ~~.01~~2,060 ~~696077403 47 93~~2,~~410~~000,000 SHCALL DEFINED 1,2 932,~~410~~000,000 0 0 ~~SUCAMPO~~PALATIN ~~PHARMACEUTICALS-CL~~TECHNOLOGIES AINC CLCOM APAR ~~864909106~~$ ~~3,253~~.01 ~~462~~696077403 766 1,~~711~~139,423 SH DEFINED 1,2 ~~462~~1,~~711~~139,423 0 0 ~~SCICLONE~~SHANGPHARMA ~~PHARMACEUTICALS~~CORP ~~INC~~SPONSORED ~~COM~~ADR ~~80862K104~~81943P104 83,~~763~~247 1426,~~250,000~~056 SH DEFINED 1,2 1426,~~250,000~~056 0 0 ~~SANOFI~~SUNESIS ~~SPONSORED~~PHARMACEUTICALS ~~ADR~~INC ~~80105N105~~COM 5NEW 867328601 6,~~020~~124 ~~132~~1,~~868~~083,925 SH DEFINED 1,2 ~~132~~1,~~868~~083,925 0 0 TEVA PHARMACEUTICAL INDS LTD ADR 881624209 2224,~~927~~072 581,315 SH DEFINED 1,2 581,315 0 0 THRESHOLD PHARMACEUTICAL INC COM NEW 885807206 36,~~736~~189 ~~504~~854,846 SH DEFINED 1,2 ~~504~~854,846 0 0 ~~WELLPOINT~~YM BIOSCIENCES INC COM ~~94973V107~~984238105 13,~~231~~707 192,~~300~~014,918 SH DEFINED 1,2 192,~~300~~014,918 0 0 YMUNIVERSAL ~~BIOSCIENCES~~HLTH SVCS INC ~~COM~~CL ~~984238105~~B 1913903100 3,~~486~~110 ~~750~~68,~~400~~000 SH DEFINED 1,2 ~~750~~68,~~400~~000 0 0 ~~ONCOTHYREON~~ZIOPHARM ONCOLOGY INC COM ~~682324908~~98973P101 24,~~290~~409 ~~489~~809,~~300~~009 ~~CALL~~SH DEFINED 1,2 ~~489~~809,~~300~~009 0 0

Filing Compare · Ayer Capital Management, LP